BNT111
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BNT111, covering 2025-12-15 to 2025-12-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of Treatment [Phase 2]